Fatty liver contributes significantly to the progression of coronary artery disease in patients with metabolic syndrome

被引：0
作者：
Takata, K.
Toyota, Y.
Hiraoka, A.
Mitauba, N.
Takahashi, I.
Ohta, T.
机构：
[1] Hroshima Railway Hosp, Hiroshima, Japan
[2] Univ Ryukyus, Okinawa, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2006年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1567-5688(06)81454-6
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：367 / 368
页数：2
相关论文
共 50 条
  • [41] Circulating exosomal biomarkers in patients with coronary artery disease and metabolic syndrome
    Kayumov, N.
    Uzokov, J.
    Alyavi, B.
    Bekzod, K.
    Madjidov, I.
    Mukhamedova, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2022, 52
  • [42] Incidence and clinical characteristics of the metabolic syndrome in patients with coronary artery disease
    Solymoss, BC
    Bourassa, MG
    Lespérance, J
    Levesque, S
    Marcil, M
    Varga, S
    Campeau, L
    CORONARY ARTERY DISEASE, 2003, 14 (03) : 207 - 212
  • [43] BLOOD PRESSURE PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE AND METABOLIC SYNDROME
    Sobiczewski, W.
    Wirtwein, M.
    Jaguszewski, M.
    Gruchala, M.
    Rynkiewicz, A.
    JOURNAL OF HYPERTENSION, 2009, 27 : S402 - S402
  • [44] EFFECT OF METABOLIC SYNDROME ON PROGNOSIS OF REVASCULARIZATION IN PATIENTS WITH CORONARY ARTERY DISEASE
    Hu Rong
    Ma Changsheng
    Nie Shaoping
    Lv Qiang
    Kang Junping
    Liu Xiaohui
    HEART, 2010, 96 : A116 - A117
  • [45] RELATIONSHIP OF THE METABOLIC SYNDROME AND CORONARY ARTERY DISEASE IN PATIENTS WITH STABLE ANGINA
    Sadeghi, M.
    Garak-Yaraghi, M.
    Saneie, H.
    Rozati, G.
    Roohafza, H.
    Talaei, M.
    ARYA ATHEROSCLEROSIS, 2006, 2 (01) : 10 - 14
  • [46] Metabolic syndrome does not impact survival of patients with coronary artery disease
    Shah, Binita
    Kumar, Nidhi
    Garg, Parveen
    Kang, Eunice Y.
    Grossi, Eugene
    Lorin, Jeffrey D.
    Schwartzbard, Arthur Z.
    Danoff, Ann
    Sedlis, Steven P.
    CIRCULATION, 2006, 114 (18) : 849 - 849
  • [47] PREVALENCE OF METABOLIC SYNDROME IN CORONARY ARTERY DISEASE AND CEREBROVASCULAR ACCIDENT PATIENTS
    Ramakrishna, G.
    Kumar, P. V. Kalyan
    Ramakrishna, R.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2019, 8 (04):
  • [48] Metabolic Syndrome Associates With Resistance to Aspirin in Patients With Coronary Artery Disease
    Smith, James P.
    Haddad, Elias V.
    Boutaud, Olivier
    Oram, Denise A.
    Blakemore, Dana L.
    Chen, Qingxia
    Taylor, Mary B.
    Oates, John A.
    CIRCULATION, 2009, 120 (18) : S1033 - S1033
  • [49] Risk factors of the metabolic syndrome in patients with nonalcoholic fatty liver disease
    Uzcategui, Lilia R.
    Gegorio Angel, Jose
    Martinez, Dasyl
    Gomez-Perez, Roald
    Arata-Bellabarba, G.
    MEDULA, 2008, 17 (01): : 7 - 14
  • [50] Plasma adipocytokines in patients with metabolic syndrome and nonalcoholic fatty liver disease
    Diaconu, L.
    Serban, V.
    Timar, R. Z.
    Vlad, A.
    Timar, B.
    Mazilu, C.
    Botea, V.
    DIABETOLOGIA, 2007, 50 : S294 - S295
12345